Maldives vs South Sudan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Maldives
2.0%
in 2025
South Sudan
27.0%
in 2025
Maldives rank
166th
South Sudan rank
163rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Maldives
- South Sudan
How they compare
South Sudan currently reports 27.0% against 2.0% in Maldives, a difference of 25.0%.
That makes South Sudan's figure about 13.5 times Maldives's.
Across all 15 years both countries report, South Sudan has been ahead every year.
Maldives ranks 166th and South Sudan ranks 163rd of 194 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Maldives | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.3% | 4.5% | 4.2% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Maldives or South Sudan?
- South Sudan, at 27.0% against 2.0% in Maldives as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Maldives and South Sudan?
- 25.0%, with South Sudan ahead.
- How many years of comparable data are there for Maldives and South Sudan?
- 15 years are reported by both, from 2011 to 2025.
- How do Maldives and South Sudan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Maldives ranks 166th and South Sudan ranks 163rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.